Molecular diagnostics of a single drug-resistant multiple myeloma case using targeted next-generation sequencing
Open Access
- 1 October 2015
- journal article
- case report
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. 8, 2805-2815
Abstract
A 69-year-old man was diagnosed with IgG λ-type multiple myeloma (MM), Stage II in October 2010. He was treated with one cycle of high-dose dexamethasone. After three cycles of bortezomib, the patient exhibited slow elevations in the free light-chain levels and developed a significant new increase of serum M protein. Bone marrow cytogenetic analysis revealed a complex karyotype characteristic of malignant plasma cells. To better understand the molecular pathogenesis of this patient, we sequenced for mutations in the entire coding regions of 409 cancer-related genes using a semiconductor-based sequencing platform. Sequencing analysis revealed eight nonsynonymous somatic mutations in addition to several copy number variants, including CCND1 and RB1. These alterations may play roles in the pathobiology of this disease. This targeted next-generation sequencing can allow for the prediction of drug resistance and facilitate improvements in the treatment of MM patients.Keywords
This publication has 20 references indexed in Scilit:
- Ion Torrent sequencing for conducting genome-wide scans for mutation mapping analysisMammalian Genome, 2013
- Initial genome sequencing and analysis of multiple myelomaNature, 2011
- Immunomodulatory effects of lenalidomide and pomalidomide on interaction of tumor and bone marrow accessory cells in multiple myelomaBlood, 2010
- A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myelomaBlood, 2010
- The Monoclonal Antibody nBT062 Conjugated to Cytotoxic Maytansinoids Has Selective Cytotoxicity Against CD138-Positive Multiple Myeloma CellsIn vitroandIn vivoClinical Cancer Research, 2009
- Bortezomib-Resistant Nuclear Factor-κB Activity in Multiple Myeloma CellsMolecular Cancer Research, 2008
- Unregulated smooth-muscle myosin in human intestinal neoplasiaProceedings of the National Academy of Sciences, 2008
- Promoter Methylation of Genes in and around the Candidate Lung Cancer Susceptibility Locus6q23-25Cancer Research, 2008
- Comparing the DNA Hypermethylome with Gene Mutations in Human Colorectal CancerPLOS Genetics, 2007
- Clinical and biologic implications of recurrent genomic aberrations in myelomaBlood, 2003